chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Malaise, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: I was feeling sick after the end of November and then about a week later I was feeling like I was over the sickness and better, but it came back. I was having a fever; body aches and chills along with a cough that is still linger today. I was also so tired and exhausted during all of this and slept a lot more than I normally do. I was on a trip and the hotel had an urgent care, so I went there, and they tested me for COVID-19 and Influenza. I was negative for COVID but positive for Influenza A. Even though I was past the time frame for TAMIFLU, but the provider did set me a prescription for that. I do not think that the medication helped but it gave me peace of mind to try it. I started feeling better on about the 8 or 9th which was right before I flew home from my trip.
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Vaccination site pain
Clinical narrative: Pt has recurrent right shoulder pain with soreness in the same area that she received her vaccine. It has been 3 mo since her vaccine and she gets this soreness every two weeks and it lasts for 2-3 days.
Age: 34.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Wrong vial was grabbed out of the fridge and not properly verified. Patient was supposed to get the Pfizer dose 1 of the original series, but instead received the updated booster. No signs or symptoms prior to patient leaving the store.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Herpes zoster, Myalgia, Neuralgia, Rash
Clinical narrative: Day of vaccine significant muscle pain throughout body. This last through the next day. Then Dec 21 developed muscle and nerve pain down left leg from buttocks/vaginal area to foot. Dec 23 in the morning noted a rash. That evening diagnosed with shingles. I continue to have shingles at this time. I am 39 years old, so a bit young for shingles. I do not have a weakened immune system or other reasons for developing shingles. I actually have pretty strong immune system as I've been a health care worker for about 15 years, so I've been exposed to a lot.
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Galactorrhoea
Clinical narrative: patient stated she started lactating after receiving vaccine
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: On December 5th my symptoms began with a sore throat. I took a rapid test and it was positive. The next day I called my doctor and explained my symptoms. He recommended that I take PAXLOVID and began taking it on December 7th. The only other symptom I had was a headache. The symptoms lasted about 5 days.
Age: 71.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Cough, Discharge, Fatigue, Headache
Clinical narrative: I had sore throat, drainage, head congestion, tickled cough, fatigue, and headache. I tested positive for COVID-19 at home. My doctor prescribed me PAXLOVID. It took another 48 hours after I started feeling better. I still have a cough, headache, drainage, and fatigue. The symptoms are getting better everyday.
Age: 71.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had sore throat, drainage, head congestion, tickled cough, fatigue, and headache. I tested positive for COVID-19 at home. My doctor prescribed me PAXLOVID. It took another 48 hours after I started feeling better. I still have a cough, headache, drainage, and fatigue. The symptoms are getting better everyday.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Headache, Influenza virus test positive, Pain in extremity
Clinical narrative: Three days after vaccine I had a fever and fatigue and sore arm; also headache, lasted 2-3 days.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Three days after vaccine I had a fever and fatigue and sore arm; also headache, lasted 2-3 days.
Age: 46.0
Sex: M
Vaccine: FLUC4
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: patient stating that he had pain originating  in the center of left  deltoid and radiating downward to the middle of humerous.  states that pain is increased when raising arm to 90 degrees from midline and when trying to lift heavy objects.  Pt was seen by PCP and prescribed diclofenac. Patient states pain is lessoned but not alleviated when medicated.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Per our investigation at the Public Health Dept., the above vial of Novavax  had been opened on Wed. 12 /21/ 2022 and used to administer a vaccine.   It was immediately returned to the refrigerator that day.    Today, 12/27,2022, same vial was used to give a subsequent vaccine to the patient listed above.    The above patient was notified to watch for inappropriate redness or soreness to the area and to report to our office.   Efficacy is considered unharmed as the vial was kept in the main refrigerator between usages and no temperature excursions occurred.     Novavax was also contacted for follow up.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient received a second dose of the pfizer bivalent vaccine which is not within guidelines.  Patient has reported no adverse event.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Cerebral ischaemia
Clinical narrative: Patient is a 85 y.o. female patient of PA-C with history of COPD, hyperlipidemia, recent ischemic CVA at left thalamus in July 2022 presents to the hospital with complaints of weakness and nausea on 12/1/2022.   Covid-19 pneumonia Acute hypoxemic respiratory failure:  Date of onset of symptoms: Unclear on exact date as she had pulmonary symptoms at the time of admission due to community-acquired pneumonia (likely bacterial).  Her COVID-19 molecular testing was negative on 11/30/2022 at outside hospital and became febrile with increased oxygen requirement on 12/8/2022, testing positive at that point in time. Date of covid positive test: 12/8/2022 Vaccination status: vaccinated (mRNA vaccines x2, no booster) Imaging: Chest x-ray on 12/8/2022 showing patchy interstitial bilateral opacities. Oxygen requirements: On 4 L nasal cannula at time of COVID-19 diagnosis  Current oxygen requirements: Room air Medical therapy: remdesivir and steroids, status post tocilizumab on 12/9/2022 Consultants following: Infectious disease Anticipated special isolation end date: 12/18/2022   Community-acquired multifocal pneumonia, bilateral lower lobes Sepsis, POA now resolved Lactic acidosis, POA CT chest abdomen pelvis personally reviewed and showing multifocal groundglass opacities most prominent in upper lobes. Treated with empiric vancomycin and cefepime on admission with improvement and de-escalated to ceftriaxone, now status post 7 days therapy Worsening respiratory status secondary to COVID-19 pneumonia as above, antibiotics discontinued   History of COPD: Without acute exacerbation Continue as needed albuterol   Generalized weakness 2/2 sepsis: PT/OT evaluated and recommend home health on discharge CT head reviewed with no acute abnormalities.   Sinus arrhythmia Patient's EKG showing sinus arrhythmia Troponin x3 negative. No chest pain.     History of CVA: Continue aspirin and statin   Nonspecific multifocal lucencies in thoracolumbar spine Incidental finding found on CT chest abdomen and pelvis Follow-up with none urgent MRI in outpatient setting  Hypokalemia Trending chemistry Monitor and replace
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Computerised tomogram head normal, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 85 y.o. female patient of PA-C with history of COPD, hyperlipidemia, recent ischemic CVA at left thalamus in July 2022 presents to the hospital with complaints of weakness and nausea on 12/1/2022.   Covid-19 pneumonia Acute hypoxemic respiratory failure:  Date of onset of symptoms: Unclear on exact date as she had pulmonary symptoms at the time of admission due to community-acquired pneumonia (likely bacterial).  Her COVID-19 molecular testing was negative on 11/30/2022 at outside hospital and became febrile with increased oxygen requirement on 12/8/2022, testing positive at that point in time. Date of covid positive test: 12/8/2022 Vaccination status: vaccinated (mRNA vaccines x2, no booster) Imaging: Chest x-ray on 12/8/2022 showing patchy interstitial bilateral opacities. Oxygen requirements: On 4 L nasal cannula at time of COVID-19 diagnosis  Current oxygen requirements: Room air Medical therapy: remdesivir and steroids, status post tocilizumab on 12/9/2022 Consultants following: Infectious disease Anticipated special isolation end date: 12/18/2022   Community-acquired multifocal pneumonia, bilateral lower lobes Sepsis, POA now resolved Lactic acidosis, POA CT chest abdomen pelvis personally reviewed and showing multifocal groundglass opacities most prominent in upper lobes. Treated with empiric vancomycin and cefepime on admission with improvement and de-escalated to ceftriaxone, now status post 7 days therapy Worsening respiratory status secondary to COVID-19 pneumonia as above, antibiotics discontinued   History of COPD: Without acute exacerbation Continue as needed albuterol   Generalized weakness 2/2 sepsis: PT/OT evaluated and recommend home health on discharge CT head reviewed with no acute abnormalities.   Sinus arrhythmia Patient's EKG showing sinus arrhythmia Troponin x3 negative. No chest pain.     History of CVA: Continue aspirin and statin   Nonspecific multifocal lucencies in thoracolumbar spine Incidental finding found on CT chest abdomen and pelvis Follow-up with none urgent MRI in outpatient setting  Hypokalemia Trending chemistry Monitor and replace
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Hypokalaemia, Laboratory test, Lactic acidosis, Lung opacity
Clinical narrative: Patient is a 85 y.o. female patient of PA-C with history of COPD, hyperlipidemia, recent ischemic CVA at left thalamus in July 2022 presents to the hospital with complaints of weakness and nausea on 12/1/2022.   Covid-19 pneumonia Acute hypoxemic respiratory failure:  Date of onset of symptoms: Unclear on exact date as she had pulmonary symptoms at the time of admission due to community-acquired pneumonia (likely bacterial).  Her COVID-19 molecular testing was negative on 11/30/2022 at outside hospital and became febrile with increased oxygen requirement on 12/8/2022, testing positive at that point in time. Date of covid positive test: 12/8/2022 Vaccination status: vaccinated (mRNA vaccines x2, no booster) Imaging: Chest x-ray on 12/8/2022 showing patchy interstitial bilateral opacities. Oxygen requirements: On 4 L nasal cannula at time of COVID-19 diagnosis  Current oxygen requirements: Room air Medical therapy: remdesivir and steroids, status post tocilizumab on 12/9/2022 Consultants following: Infectious disease Anticipated special isolation end date: 12/18/2022   Community-acquired multifocal pneumonia, bilateral lower lobes Sepsis, POA now resolved Lactic acidosis, POA CT chest abdomen pelvis personally reviewed and showing multifocal groundglass opacities most prominent in upper lobes. Treated with empiric vancomycin and cefepime on admission with improvement and de-escalated to ceftriaxone, now status post 7 days therapy Worsening respiratory status secondary to COVID-19 pneumonia as above, antibiotics discontinued   History of COPD: Without acute exacerbation Continue as needed albuterol   Generalized weakness 2/2 sepsis: PT/OT evaluated and recommend home health on discharge CT head reviewed with no acute abnormalities.   Sinus arrhythmia Patient's EKG showing sinus arrhythmia Troponin x3 negative. No chest pain.     History of CVA: Continue aspirin and statin   Nonspecific multifocal lucencies in thoracolumbar spine Incidental finding found on CT chest abdomen and pelvis Follow-up with none urgent MRI in outpatient setting  Hypokalemia Trending chemistry Monitor and replace
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pneumonia, Pneumonia bacterial, Pyrexia, Respiratory symptom
Clinical narrative: Patient is a 85 y.o. female patient of PA-C with history of COPD, hyperlipidemia, recent ischemic CVA at left thalamus in July 2022 presents to the hospital with complaints of weakness and nausea on 12/1/2022.   Covid-19 pneumonia Acute hypoxemic respiratory failure:  Date of onset of symptoms: Unclear on exact date as she had pulmonary symptoms at the time of admission due to community-acquired pneumonia (likely bacterial).  Her COVID-19 molecular testing was negative on 11/30/2022 at outside hospital and became febrile with increased oxygen requirement on 12/8/2022, testing positive at that point in time. Date of covid positive test: 12/8/2022 Vaccination status: vaccinated (mRNA vaccines x2, no booster) Imaging: Chest x-ray on 12/8/2022 showing patchy interstitial bilateral opacities. Oxygen requirements: On 4 L nasal cannula at time of COVID-19 diagnosis  Current oxygen requirements: Room air Medical therapy: remdesivir and steroids, status post tocilizumab on 12/9/2022 Consultants following: Infectious disease Anticipated special isolation end date: 12/18/2022   Community-acquired multifocal pneumonia, bilateral lower lobes Sepsis, POA now resolved Lactic acidosis, POA CT chest abdomen pelvis personally reviewed and showing multifocal groundglass opacities most prominent in upper lobes. Treated with empiric vancomycin and cefepime on admission with improvement and de-escalated to ceftriaxone, now status post 7 days therapy Worsening respiratory status secondary to COVID-19 pneumonia as above, antibiotics discontinued   History of COPD: Without acute exacerbation Continue as needed albuterol   Generalized weakness 2/2 sepsis: PT/OT evaluated and recommend home health on discharge CT head reviewed with no acute abnormalities.   Sinus arrhythmia Patient's EKG showing sinus arrhythmia Troponin x3 negative. No chest pain.     History of CVA: Continue aspirin and statin   Nonspecific multifocal lucencies in thoracolumbar spine Incidental finding found on CT chest abdomen and pelvis Follow-up with none urgent MRI in outpatient setting  Hypokalemia Trending chemistry Monitor and replace
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Sinus arrhythmia, Spinal disorder, Troponin normal
Clinical narrative: Patient is a 85 y.o. female patient of PA-C with history of COPD, hyperlipidemia, recent ischemic CVA at left thalamus in July 2022 presents to the hospital with complaints of weakness and nausea on 12/1/2022.   Covid-19 pneumonia Acute hypoxemic respiratory failure:  Date of onset of symptoms: Unclear on exact date as she had pulmonary symptoms at the time of admission due to community-acquired pneumonia (likely bacterial).  Her COVID-19 molecular testing was negative on 11/30/2022 at outside hospital and became febrile with increased oxygen requirement on 12/8/2022, testing positive at that point in time. Date of covid positive test: 12/8/2022 Vaccination status: vaccinated (mRNA vaccines x2, no booster) Imaging: Chest x-ray on 12/8/2022 showing patchy interstitial bilateral opacities. Oxygen requirements: On 4 L nasal cannula at time of COVID-19 diagnosis  Current oxygen requirements: Room air Medical therapy: remdesivir and steroids, status post tocilizumab on 12/9/2022 Consultants following: Infectious disease Anticipated special isolation end date: 12/18/2022   Community-acquired multifocal pneumonia, bilateral lower lobes Sepsis, POA now resolved Lactic acidosis, POA CT chest abdomen pelvis personally reviewed and showing multifocal groundglass opacities most prominent in upper lobes. Treated with empiric vancomycin and cefepime on admission with improvement and de-escalated to ceftriaxone, now status post 7 days therapy Worsening respiratory status secondary to COVID-19 pneumonia as above, antibiotics discontinued   History of COPD: Without acute exacerbation Continue as needed albuterol   Generalized weakness 2/2 sepsis: PT/OT evaluated and recommend home health on discharge CT head reviewed with no acute abnormalities.   Sinus arrhythmia Patient's EKG showing sinus arrhythmia Troponin x3 negative. No chest pain.     History of CVA: Continue aspirin and statin   Nonspecific multifocal lucencies in thoracolumbar spine Incidental finding found on CT chest abdomen and pelvis Follow-up with none urgent MRI in outpatient setting  Hypokalemia Trending chemistry Monitor and replace
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Musculoskeletal stiffness, Pain in extremity, Rheumatoid arthritis
Clinical narrative: I started having stiffness and pain in both of my hands a couple days after the vaccination. It stopped for a while in March then it came back in April, and from there it started to get worse. I went to the doctor, and I was diagnosed with Rheumatoid arthritis.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Fatigue, Hypersomnia, Malaise, Nasopharyngitis
Clinical narrative: On November 8th I had a sore throat, but it was mild. The next day I began to feel like I was catching a cold because I was sneezing and had some coughing. Thursday morning, I didn't feel well. My first at home test was negative. I went to an urgent care. They did a rapid COVID-19 test and it was negative. Friday, I received information that the PCR test for COVID-19 was positive. I contacted my doctor and requested PAXLOVID. I began taking the medicine and began to feel better on that Saturday. I was very tired and achy. I stopped taking my statin drug on Thursday because I was told it was not compatible with PAXLOVID. As of Monday, I felt better but was still tired and did a lot of napping. The following Sunday, 10 days later, I was feeling back to normal.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pain, SARS-CoV-2 test positive, Sneezing
Clinical narrative: On November 8th I had a sore throat, but it was mild. The next day I began to feel like I was catching a cold because I was sneezing and had some coughing. Thursday morning, I didn't feel well. My first at home test was negative. I went to an urgent care. They did a rapid COVID-19 test and it was negative. Friday, I received information that the PCR test for COVID-19 was positive. I contacted my doctor and requested PAXLOVID. I began taking the medicine and began to feel better on that Saturday. I was very tired and achy. I stopped taking my statin drug on Thursday because I was told it was not compatible with PAXLOVID. As of Monday, I felt better but was still tired and did a lot of napping. The following Sunday, 10 days later, I was feeling back to normal.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Presyncope
Clinical narrative: Patient felt dizziness following vaccination and required attention from pharmacist after almost fainting
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: Medical Assistant gave Bivalent Booster for age 5-11year old without diluting the product first. Pt received 0.2ml of undiluted Bivalent 5-11 yr Vaccine in her left deltoid. Patient (Grandparent)  has been contacted. Employee has been placed on suspension pending investigation. Patient has a follow up appt to check up in a couple of days
Age: 17.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Dose error: patient received >18 y/o 0.1 ID dose of MPOX vaccine instead of 0.5 mL SQ at 1403 on 12/27/22. No s/sx or adverse effects.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, COVID-19, Computerised tomogram thorax normal
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of (city,state) with history of hypertension, hyperlipidemia, type 2 diabetes, obesity presented to Hospital with shortness of air.   Patient reports she developed shortness of air 3 days prior to presentation.  She also has been extremely fatigued and had a cough productive of clear mucus.  She has had intermittent vomiting.  She denies any diarrhea.  She reports decreased p.o. intake and subjective fever.  Denies any sick contacts.   Acute hypoxemic respiratory failure secondary to COVID-19 Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Shortness of air, cough, fatigue Date of covid positive test: 12/11 Vaccination status: Unknown Imaging: CT PE: No PE, no acute cardiopulmonary process Oxygen requirements on admission: 3L Current oxygen requirements: room air Medical therapy: steroids (refuses remdesevir) Consultants following: ID Anticipated special isolation end date: 12/21 O2 was weaned off during this hospital admission   AKI-resolved Baseline creatinine 1.02 Creatinine 1.48>1.3>1 Held home meloxicam, losartan, hydrochlorothiazide in setting of  Held home metformin S/P IVF  Renal dose medications   Type 2 diabetes Patient on metformin at home previously on insulin but reports has been on hold given low A1c Hold metformin at this time given AKI Sliding scale insulin while inpatient and on steroids Dc on oral DM meds, no insulin as she states this was discontinued   Hypertension Patient's blood pressure has been low normal while inpatient despite not taking her antihypertensives today Hold losartan, hydrochlorothiazide due to AKI Restart home coreg Resume home meds on DC  Morbid Obesity BMI 57 Lifestyle modification
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Glycosylated haemoglobin decreased, Hypertension, Hypophagia
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of (city,state) with history of hypertension, hyperlipidemia, type 2 diabetes, obesity presented to Hospital with shortness of air.   Patient reports she developed shortness of air 3 days prior to presentation.  She also has been extremely fatigued and had a cough productive of clear mucus.  She has had intermittent vomiting.  She denies any diarrhea.  She reports decreased p.o. intake and subjective fever.  Denies any sick contacts.   Acute hypoxemic respiratory failure secondary to COVID-19 Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Shortness of air, cough, fatigue Date of covid positive test: 12/11 Vaccination status: Unknown Imaging: CT PE: No PE, no acute cardiopulmonary process Oxygen requirements on admission: 3L Current oxygen requirements: room air Medical therapy: steroids (refuses remdesevir) Consultants following: ID Anticipated special isolation end date: 12/21 O2 was weaned off during this hospital admission   AKI-resolved Baseline creatinine 1.02 Creatinine 1.48>1.3>1 Held home meloxicam, losartan, hydrochlorothiazide in setting of  Held home metformin S/P IVF  Renal dose medications   Type 2 diabetes Patient on metformin at home previously on insulin but reports has been on hold given low A1c Hold metformin at this time given AKI Sliding scale insulin while inpatient and on steroids Dc on oral DM meds, no insulin as she states this was discontinued   Hypertension Patient's blood pressure has been low normal while inpatient despite not taking her antihypertensives today Hold losartan, hydrochlorothiazide due to AKI Restart home coreg Resume home meds on DC  Morbid Obesity BMI 57 Lifestyle modification
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Productive cough, Pyrexia, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Assessment and Plan Patient is a 52 y.o. female patient of (city,state) with history of hypertension, hyperlipidemia, type 2 diabetes, obesity presented to Hospital with shortness of air.   Patient reports she developed shortness of air 3 days prior to presentation.  She also has been extremely fatigued and had a cough productive of clear mucus.  She has had intermittent vomiting.  She denies any diarrhea.  She reports decreased p.o. intake and subjective fever.  Denies any sick contacts.   Acute hypoxemic respiratory failure secondary to COVID-19 Covid-19 Virus Infection Date of onset of symptoms: 12/9 Symptoms present on admission: Shortness of air, cough, fatigue Date of covid positive test: 12/11 Vaccination status: Unknown Imaging: CT PE: No PE, no acute cardiopulmonary process Oxygen requirements on admission: 3L Current oxygen requirements: room air Medical therapy: steroids (refuses remdesevir) Consultants following: ID Anticipated special isolation end date: 12/21 O2 was weaned off during this hospital admission   AKI-resolved Baseline creatinine 1.02 Creatinine 1.48>1.3>1 Held home meloxicam, losartan, hydrochlorothiazide in setting of  Held home metformin S/P IVF  Renal dose medications   Type 2 diabetes Patient on metformin at home previously on insulin but reports has been on hold given low A1c Hold metformin at this time given AKI Sliding scale insulin while inpatient and on steroids Dc on oral DM meds, no insulin as she states this was discontinued   Hypertension Patient's blood pressure has been low normal while inpatient despite not taking her antihypertensives today Hold losartan, hydrochlorothiazide due to AKI Restart home coreg Resume home meds on DC  Morbid Obesity BMI 57 Lifestyle modification
Age: 1.08
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age
Clinical narrative: The incorrect aged dose was given, thus a higher dose was given. Gave orange dose instead of maroon. Pain in the leg was the only reported side effect to date. No fevers.
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Fatigue Body aches Fever Headache Chills  Treated with Ibuprofen Ongoing
Age: 29.0
Sex: F
Vaccine: DTAP, JEV1, RAB, YF
Symptoms: Asthenia, Confusional state, Disorientation, Erythema, Eye movement disorder
Clinical narrative: Client did fine after receiving the JE, Rabavert, and DPT vaccines. Moments after giving the YF vaccine client c/o feeling funny and confused, stated she was going to pass out. Pupils became dilated eyes rolled up, skin turned bright red, back arched and she became stiff, muscle relaxed then stiffened again, voided, then turned pale. Respirations deep and rapid, pulse easily palpated and regular, approximately 88 bpm. Head down and feet elevated. Slowly regained consciousness and color returned. Post ictal was disoriented and weak. Shortly after regaining consciousness began to vomit . Vomiting off and on for the next hour. Told to go to the ER for anti-emetics if vomiting continued on the way home. Sister was driving her home. Will be staying with father who is an MD.
Age: 29.0
Sex: F
Vaccine: DTAP, JEV1, RAB, YF
Symptoms: Feeling abnormal, Loss of consciousness, Musculoskeletal stiffness, Mydriasis, Pallor
Clinical narrative: Client did fine after receiving the JE, Rabavert, and DPT vaccines. Moments after giving the YF vaccine client c/o feeling funny and confused, stated she was going to pass out. Pupils became dilated eyes rolled up, skin turned bright red, back arched and she became stiff, muscle relaxed then stiffened again, voided, then turned pale. Respirations deep and rapid, pulse easily palpated and regular, approximately 88 bpm. Head down and feet elevated. Slowly regained consciousness and color returned. Post ictal was disoriented and weak. Shortly after regaining consciousness began to vomit . Vomiting off and on for the next hour. Told to go to the ER for anti-emetics if vomiting continued on the way home. Sister was driving her home. Will be staying with father who is an MD.
Age: 29.0
Sex: F
Vaccine: DTAP, JEV1, RAB, YF
Symptoms: Respiratory rate increased, Vomiting
Clinical narrative: Client did fine after receiving the JE, Rabavert, and DPT vaccines. Moments after giving the YF vaccine client c/o feeling funny and confused, stated she was going to pass out. Pupils became dilated eyes rolled up, skin turned bright red, back arched and she became stiff, muscle relaxed then stiffened again, voided, then turned pale. Respirations deep and rapid, pulse easily palpated and regular, approximately 88 bpm. Head down and feet elevated. Slowly regained consciousness and color returned. Post ictal was disoriented and weak. Shortly after regaining consciousness began to vomit . Vomiting off and on for the next hour. Told to go to the ER for anti-emetics if vomiting continued on the way home. Sister was driving her home. Will be staying with father who is an MD.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: I think I have shingles from the vaccine.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, Cardiac disorder, Cardiac pacemaker insertion, Chest pain, Computerised tomogram
Clinical narrative: Long time healthy individual, with normally lower (not-low) blood pressure.   Vaccinated Sep 2021.   Unexpected onset of severe chest pains and cardiac event occurred Oct 1, 2022.  Rushed to ER via ambulance.  Diagnosis: Bradycardia.  Heart rate far too low.   At one point while coconscious,  rate 37 beats per minute.   Pacemaker judged required and implanted to maintain nominal heart rate.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram, Heart rate decreased
Clinical narrative: Long time healthy individual, with normally lower (not-low) blood pressure.   Vaccinated Sep 2021.   Unexpected onset of severe chest pains and cardiac event occurred Oct 1, 2022.  Rushed to ER via ambulance.  Diagnosis: Bradycardia.  Heart rate far too low.   At one point while coconscious,  rate 37 beats per minute.   Pacemaker judged required and implanted to maintain nominal heart rate.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Nasal congestion, No adverse event, Pain
Clinical narrative: No adverse event to vaccine.  Contracted Covid - positive home test 12/11/2022.  Body aches, fever, cough, severe nasal congestion
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: No adverse event to vaccine.  Contracted Covid - positive home test 12/11/2022.  Body aches, fever, cough, severe nasal congestion
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Burning sensation, Electromyogram normal, Magnetic resonance imaging normal, Magnetic resonance imaging spinal normal, Nerve conduction studies normal
Clinical narrative: Bil burning tingling pain of both plantar surface of both feet starting in April. Symptoms worsened after 4th injection on 10/01/2022 of the Pfizer bivalent vaccine.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: Bil burning tingling pain of both plantar surface of both feet starting in April. Symptoms worsened after 4th injection on 10/01/2022 of the Pfizer bivalent vaccine.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 73.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: After first shot began experiencing tingling in feet and hands.  I also have numbness in feet and hands.  The doctor also confirmed my inability to feel temperature changes in these same areas.
Age: 48.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 8.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 11.0
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 11.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 9.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 10.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 44.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 12.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 36.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 68.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 51.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 24.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 25.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 30.0
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 18.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 66.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Condition aggravated, Granuloma annulare, Psoriasis, Rash erythematous
Clinical narrative: Developed granuloma annulare and worsening of psoriasis approximately one month after receiving the fourth dose of Pfizer COVID vaccine. Granuloma annulare first appeared as flesh colored bumps under the skin of arms and forearms and spread to torso and back. After approximately 6 months the outbreak became increasingly inflamed, red, and itchy. Psoriasis lesions on arms, elbows, forearms, and scalp became larger with more scales and skin flaking.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular, Rash pruritic, Skin exfoliation
Clinical narrative: Developed granuloma annulare and worsening of psoriasis approximately one month after receiving the fourth dose of Pfizer COVID vaccine. Granuloma annulare first appeared as flesh colored bumps under the skin of arms and forearms and spread to torso and back. After approximately 6 months the outbreak became increasingly inflamed, red, and itchy. Psoriasis lesions on arms, elbows, forearms, and scalp became larger with more scales and skin flaking.
Age: 70.0
Sex: U
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: vaccine was frozen rather than refrigerated. dose was given to patient. no symptoms reported. revaccination offered.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Cardiac disorder, Immune system disorder, Liver disorder, Liver function test increased
Clinical narrative: This student had COVID (presumed delta) in  mid December 2021. Her school required a booster to return in January 2022 if the students were eligible.  She got the booster as she was eligible per CDC guidelines.  Her roommates and she all had colds in early March of 2022. Her roommates got better, but she did not. After a weeklong hospital stay, she was diagnosed with adult onset stills disease.  It is affecting her everyday life almost a year later. It affected her heart, her liver and her immune system. She is now on lifelong medications and is immunosuppressed by them.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Red blood cell sedimentation rate increased, Serum ferritin increased, Still's disease, Troponin increased
Clinical narrative: This student had COVID (presumed delta) in  mid December 2021. Her school required a booster to return in January 2022 if the students were eligible.  She got the booster as she was eligible per CDC guidelines.  Her roommates and she all had colds in early March of 2022. Her roommates got better, but she did not. After a weeklong hospital stay, she was diagnosed with adult onset stills disease.  It is affecting her everyday life almost a year later. It affected her heart, her liver and her immune system. She is now on lifelong medications and is immunosuppressed by them.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Osteosarcoma
Clinical narrative: Patient had a recurrence of her osteosarcoma after scans were clear prior to the booster
Age: 24.0
Sex: F
Vaccine: COVID19-2
Symptoms: Alcohol use, Biopsy, Chemotherapy, Chest pain, Computerised tomogram head
Clinical narrative: My first two vaccines were completed by February of 2022. A month later I began to have chest pain with alcohol. Between this time and the time of my third vaccine i experienced increasing shortness of breath with exertion and felt a lump in my right supraclavicular region.  I received my third dose in November 2021. In March of 2022, I had generalized pruritus and skin changes begin. At my annual preventative visit in May 2022, I mentioned these things to my provider. I think went on to get an US, two CT scans, a biopsy, and a PET scan to then be diagnosed with stage four nodular sclerosing Hodgkin?s lymphoma with a mass of lymphadenopathy roughly 15cmx8cmx8cm. After this, I had PFTs and an echo done prior to starting chemotherapy. I underwent 12 infusions of chemotherapy between June 2022 and November 2022.
Age: 24.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram neck, Dyspnoea, Dyspnoea exertional, Echocardiogram, Full blood count
Clinical narrative: My first two vaccines were completed by February of 2022. A month later I began to have chest pain with alcohol. Between this time and the time of my third vaccine i experienced increasing shortness of breath with exertion and felt a lump in my right supraclavicular region.  I received my third dose in November 2021. In March of 2022, I had generalized pruritus and skin changes begin. At my annual preventative visit in May 2022, I mentioned these things to my provider. I think went on to get an US, two CT scans, a biopsy, and a PET scan to then be diagnosed with stage four nodular sclerosing Hodgkin?s lymphoma with a mass of lymphadenopathy roughly 15cmx8cmx8cm. After this, I had PFTs and an echo done prior to starting chemotherapy. I underwent 12 infusions of chemotherapy between June 2022 and November 2022.
Age: 24.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hodgkin's disease, Hodgkin's disease nodular sclerosis stage IV, Lymphadenopathy, Metabolic function test, Neck mass
Clinical narrative: My first two vaccines were completed by February of 2022. A month later I began to have chest pain with alcohol. Between this time and the time of my third vaccine i experienced increasing shortness of breath with exertion and felt a lump in my right supraclavicular region.  I received my third dose in November 2021. In March of 2022, I had generalized pruritus and skin changes begin. At my annual preventative visit in May 2022, I mentioned these things to my provider. I think went on to get an US, two CT scans, a biopsy, and a PET scan to then be diagnosed with stage four nodular sclerosing Hodgkin?s lymphoma with a mass of lymphadenopathy roughly 15cmx8cmx8cm. After this, I had PFTs and an echo done prior to starting chemotherapy. I underwent 12 infusions of chemotherapy between June 2022 and November 2022.
Age: 24.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pathology test, Positron emission tomogram, Pruritus, Pulmonary function test, Skin disorder
Clinical narrative: My first two vaccines were completed by February of 2022. A month later I began to have chest pain with alcohol. Between this time and the time of my third vaccine i experienced increasing shortness of breath with exertion and felt a lump in my right supraclavicular region.  I received my third dose in November 2021. In March of 2022, I had generalized pruritus and skin changes begin. At my annual preventative visit in May 2022, I mentioned these things to my provider. I think went on to get an US, two CT scans, a biopsy, and a PET scan to then be diagnosed with stage four nodular sclerosing Hodgkin?s lymphoma with a mass of lymphadenopathy roughly 15cmx8cmx8cm. After this, I had PFTs and an echo done prior to starting chemotherapy. I underwent 12 infusions of chemotherapy between June 2022 and November 2022.
Age: 24.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ultrasound head, Ultrasound scan
Clinical narrative: My first two vaccines were completed by February of 2022. A month later I began to have chest pain with alcohol. Between this time and the time of my third vaccine i experienced increasing shortness of breath with exertion and felt a lump in my right supraclavicular region.  I received my third dose in November 2021. In March of 2022, I had generalized pruritus and skin changes begin. At my annual preventative visit in May 2022, I mentioned these things to my provider. I think went on to get an US, two CT scans, a biopsy, and a PET scan to then be diagnosed with stage four nodular sclerosing Hodgkin?s lymphoma with a mass of lymphadenopathy roughly 15cmx8cmx8cm. After this, I had PFTs and an echo done prior to starting chemotherapy. I underwent 12 infusions of chemotherapy between June 2022 and November 2022.
Age: 57.0
Sex: M
Vaccine: UNK, COVID19-2, COVID19-2
Symptoms: Tinnitus
Clinical narrative: Tintitus
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Pallor, Vomiting
Clinical narrative: Dizzy, vomit and pale lips
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Breast pain, Chest pain, Chills, Cough, Decreased appetite
Clinical narrative: 12/7/2022- 12/9/2022  HEADACHE ,ITCHY  EYES  WITH BLURRED VISION , CHILLS, HEADACHE ,  COUGH, RUNNING NOISE , ARM SORENESS A,RMPAIN, ARM REDNESS , SWELLING ON ARM, BUMP ON ARM , 12/9-12/27/2022 LEFT ARM  PARALYSIS , SEVERE AGGRESIVE NERVE PAIN  IN LEFT ARM , TINGLING IN FINGERS { LEFT }, SWOLLEN LYMPH NODES, DIFFICULTY BREATHING ,  DULL SHARP PAIN IN BREAST , SHARP PAIN IN CHEST ,  LOSS OF APPETITE , FREQUENT URINATION ,  LOSS OF MOBILITY ,
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Dyspnoea, Erythema, Eye pruritus, Headache, Lymphadenopathy
Clinical narrative: 12/7/2022- 12/9/2022  HEADACHE ,ITCHY  EYES  WITH BLURRED VISION , CHILLS, HEADACHE ,  COUGH, RUNNING NOISE , ARM SORENESS A,RMPAIN, ARM REDNESS , SWELLING ON ARM, BUMP ON ARM , 12/9-12/27/2022 LEFT ARM  PARALYSIS , SEVERE AGGRESIVE NERVE PAIN  IN LEFT ARM , TINGLING IN FINGERS { LEFT }, SWOLLEN LYMPH NODES, DIFFICULTY BREATHING ,  DULL SHARP PAIN IN BREAST , SHARP PAIN IN CHEST ,  LOSS OF APPETITE , FREQUENT URINATION ,  LOSS OF MOBILITY ,
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Mobility decreased, Monoplegia, Neuralgia, Pain, Pain in extremity
Clinical narrative: 12/7/2022- 12/9/2022  HEADACHE ,ITCHY  EYES  WITH BLURRED VISION , CHILLS, HEADACHE ,  COUGH, RUNNING NOISE , ARM SORENESS A,RMPAIN, ARM REDNESS , SWELLING ON ARM, BUMP ON ARM , 12/9-12/27/2022 LEFT ARM  PARALYSIS , SEVERE AGGRESIVE NERVE PAIN  IN LEFT ARM , TINGLING IN FINGERS { LEFT }, SWOLLEN LYMPH NODES, DIFFICULTY BREATHING ,  DULL SHARP PAIN IN BREAST , SHARP PAIN IN CHEST ,  LOSS OF APPETITE , FREQUENT URINATION ,  LOSS OF MOBILITY ,
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Paraesthesia, Peripheral swelling, Pollakiuria, Rhinorrhoea, Vision blurred
Clinical narrative: 12/7/2022- 12/9/2022  HEADACHE ,ITCHY  EYES  WITH BLURRED VISION , CHILLS, HEADACHE ,  COUGH, RUNNING NOISE , ARM SORENESS A,RMPAIN, ARM REDNESS , SWELLING ON ARM, BUMP ON ARM , 12/9-12/27/2022 LEFT ARM  PARALYSIS , SEVERE AGGRESIVE NERVE PAIN  IN LEFT ARM , TINGLING IN FINGERS { LEFT }, SWOLLEN LYMPH NODES, DIFFICULTY BREATHING ,  DULL SHARP PAIN IN BREAST , SHARP PAIN IN CHEST ,  LOSS OF APPETITE , FREQUENT URINATION ,  LOSS OF MOBILITY ,
Age: 0.25
Sex: F
Vaccine: HEP, PNC13
Symptoms: Peripheral swelling, Ultrasound Doppler normal
Clinical narrative: Mother reported swelling to  R leg after PCV13 vaccine. Mother noted no pain or discoloration. Swelling progressed to the thigh., them mother noted swelling to hands. Went to ER, where lab work done. Pt seen in our office on 5/29/2018,  with swelling to R LE (measurements done).
Age: 58.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Limb mass
Clinical narrative: Patient has had left shoulder pain with a small palpable mass detected in the anterior left shoulder he reports since receiving this vaccination on this date. Unknown if this is related to the vaccination or not.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Dystonia, Pulmonary embolism
Clinical narrative: Pulmonary embolism, Dystonia Recovered from PE Struggling with Dystonia, Starting Treatment
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: ADMINISTERED MONOVALENT INSTEAD OF THE BIVALENT. NO ADVERESE SYMPTOMS REPORTED BY PATIENT
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: ADMINISTERED MONOVALENT INSTEAD OF THE BIVALENT. NO ADVERESE SYMPTOMS REPORTED BY PATIENT
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: ADMINISTERED MONOVALENT INSTEAD OF THE BIVALENT. NO ADVERESE SYMPTOMS REPORTED BY PATIENT